The Efficacy of a Pseudoallergen-Free Diet in the Treatment of Chronic Idiopathic Urticaria and/or Angioedema

Sponsor
Bayside Health (Other)
Overall Status
Unknown status
CT.gov ID
NCT00163839
Collaborator
(none)
50
1

Study Details

Study Description

Brief Summary

This study involves investigating the effects of a pseudoallergen-free (active) diet compared with a control (placebo) diet in the treatment of Chronic Idiopathic Urticaria (CIU) and/or Angioedema. The hypothesis is that over a four-week intervention period, the pseudoallergen-free diet will be more effective than the placebo diet in reducing the frequency and severity of CIU and/or Angioedema.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Dietary Therapy
N/A

Detailed Description

The role of dietary pseudoallergens as a trigger for CIU and/or Angioedema is a controversial subject. 'Dietary Pseudoallergy' refers to the mimicking of IgE symptoms (such as rash, itch and swelling) by components of food in the absence of a true IgE mediated response (as diagnosed by RAST and skin prick testing).

The pseudoallergen-free diet excludes a range of naturally occuring chemicals (including salicylates, amines and brewers yeast) in addition to a range of artificial preservatives and additives (for example sulphites and glutamates). The control diet is based on the general dietary guidelines for the management of diabetes (including the principles of healthy eating, low glycemic index choices and a reduced saturated fat intake).

Subjects recruited into the study will have a 3 month history of CIU and/or Angioedema and will be randomly assigned to either the active or control arm of the study in a single blinded fashion. All subjects will be advised to cease antihistamine medication and will receive one-on-one dietary counselling by a Dietitian. The diet to which each subject has been assigned (ie either active or placebo) is to be followed for a 4 week duration. The frequency and severity of CIU and/or Angioedema as well as adherence to the diet are to be measured on both a daily and weekly basis by the subject via the completion of a clinical score card. The results of the score cards will be collated to determine the relative effects of each diet on these conditions.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
50 participants
Allocation:
Randomized
Intervention Model:
Single Group Assignment
Masking:
Single
Primary Purpose:
Treatment
Official Title:
The Efficacy of a Pseudoallergen-Free Diet in the Treatment of Chronic Idiopathic Urticaria or Angioedema: A Randomised Controlled Study
Study Start Date :
Sep 1, 2005

Outcome Measures

Primary Outcome Measures

  1. The frequency and severity of CIU and/or angioedema (as determined via a five point rating scale) []

Secondary Outcome Measures

  1. The relative use of antihistamines (ie how many, how often) []

Eligibility Criteria

Criteria

Ages Eligible for Study:
21 Years to 75 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • English Speaking

  • Aged between 21 to 75 years

  • 3 month history of Chronic Idiopathic Urticaria and/or Angioedema

Exclusion Criteria:
  • age <21 and >75 years

  • non english speaking

  • systemic lupus erythematosis

  • dysproteinemias

  • thyrotoxicosis

  • vasculitis

  • infection

Contacts and Locations

Locations

Site City State Country Postal Code
1 Alfred Hospital Melbourne Victoria Australia 3004

Sponsors and Collaborators

  • Bayside Health

Investigators

  • Principal Investigator: Kate Connell, Masters, Alfred Hospital, Melbourne, Australia

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
, ,
ClinicalTrials.gov Identifier:
NCT00163839
Other Study ID Numbers:
  • 30/05
  • Ph: 00613 9276 3063
First Posted:
Sep 14, 2005
Last Update Posted:
Feb 16, 2012
Last Verified:
Sep 1, 2005
Keywords provided by , ,
Additional relevant MeSH terms:

Study Results

No Results Posted as of Feb 16, 2012